首页> 外文期刊>Bioorganic and medicinal chemistry >Novel potassium channel openers. Part 4: transformation of the 1,4-benzoxazine skeleton into 1,4-benzothiazine, 1,2,3,4-tetrahydroquinoline, 1,2,3,4-tetrahydroquinoxaline, indoline, and 1,5-benzoxazepine.
【24h】

Novel potassium channel openers. Part 4: transformation of the 1,4-benzoxazine skeleton into 1,4-benzothiazine, 1,2,3,4-tetrahydroquinoline, 1,2,3,4-tetrahydroquinoxaline, indoline, and 1,5-benzoxazepine.

机译:新型钾通道开放剂。第4部分:将1,4-苯并恶嗪骨架转变为1,4-苯并噻嗪,1,2,3,4-四氢喹啉,1,2,3,4-四氢喹喔啉,二氢吲哚和1,5-苯并a氮平。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

As part of a search for a new potassium channel opener, the 1,4-benzoxazine skeleton derived from the benzopyran skeleton of cromakalim, was transformed into other fused rings such as 1,4-benzothiazine, 1,2,3,4-tetrahydroquinoline, 1,2,3,4-tetrahydroquinoxaline, indoline, and 1,5-benzoxazepine. The 1,4-benzothiazine derivative displayed approximately 20 times more potent vasorelaxant activity than cromakalim.
机译:作为寻找新的钾通道开放剂的一部分,将源自克罗马卡林的苯并吡喃骨架的1,4-苯并恶嗪骨架转化为其他稠合环,例如1,4-苯并噻嗪,1,2,3,4-四氢喹啉,1,2,3,4-四氢喹喔啉,二氢吲哚和1,5-苯并x氮平。 1,4-苯并噻嗪衍生物的有效血管舒张活性比克罗卡林高约20倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号